/PRNewswire/ A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled.
Secondary analyses of the phase 3 ADVANCE trial showed atogepant, a CGRP receptor antagonist, is superior to placebo across several migraine responder outcomes.
Global law firm Goodwin Procter LLP will pay pharmaceutical company BioDelivery Sciences International Inc. $850,000 in cash to settle a shareholder derivative class action filed after the company illegally amended its charter in 2018 without proper shareholder approval.